BRD2 and glioblastoma: BET inhibitors were employed to target MES gene expression and sensitize GBM to radiation therapy.<h4>Results</h4>We found that PTEN loss induces RelA chromatin localization and acetylation-mediated recruitment of BRD2 to the MES gene promoters.